Delivery Order SPE2DB20D9331-SPE2DB25FL1Y0
- Not listed
- On August 18, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $32,499.90 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge, IL. This award represents a firm fixed-price delivery order under the company's larger Indefinite Delivery Contract with the DLA, valued...
- On August 1, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, which is scheduled for completion by August 22, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor on this award. The delivery order is...
- On July 18, 2025, the Defense Logistics Agency awarded a delivery order valued at $487,498.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order is expected to be completed by August 8, 2025, with performance taking place at the vendor's Park Ridge facility. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete...
- This delivery order, issued on August 8, 2025, by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, covers the supply of Stelara 90 mg/ml syringes with a ceiling value of $16,249.95. The contract is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, and represents a specific pharmaceutical fulfillment under DMS Pharmaceutical Group's larger Indefinite...
- On August 11, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract calls for the delivery of Stelara 90 mg/ml syringes, with an ultimate completion date of September 2, 2025. This delivery order was issued without a set-aside designation, leveraging the vendor's competitive positioning as a woman-owned small business...
- The Defense Logistics Agency awarded a $32,499.90 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on August 29, 2025, for the supply of Stelara 90 mg/ml syringes. The delivery order, issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, represents a direct pharmaceutical supply fulfillment to support military healthcare operations. Performance is scheduled for completion by September 22, 2025, with...
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award was made on September 10, 2025, with an ultimate completion date of October 1, 2025. This delivery order carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on a competitive basis leveraging its established...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award, issued on August 14, 2025, with an ultimate completion date of September 5, 2025, carries a firm fixed-price arrangement with no set-aside designation. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. The award represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 22, 2025, for the supply of Stelara 90 mg/ml syringes. The award carries an ultimate completion date of August 12, 2025, and involves no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. This delivery order falls under the...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1Y0Delivery Order
On September 9, 2025, the Defense Logistics Agency awarded a delivery order valued at $48,749.85 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. The award represents a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery at its Park Ridge location. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which authorizes the agency to procure a broad range of pharmaceutical products and medical supplies supporting military healthcare facilities worldwide. The company has established itself as a key supplier within the federal pharmaceutical supply chain, with a robust portfolio of contract awards covering prescription medications, biologics, and medical consumables. Stelara, an immunosuppressant medication, represents one of the specialized pharmaceutical products the contractor regularly supplies to Department of Defense healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.7k | 9/9/25 |